![Hui Ping Jiang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Ping Jiang
General Counsel at
VALERIO THERAPEUTICS
Profile
Hui Ping Jiang is currently the Chief Regulatory Officer at Valerio Therapeutics SA. Previously, she held the position of President & Director at Qx Therapeutics, Inc. and Senior Vice President & Head-Regulatory Affairs at Epizyme, Inc. She holds a doctorate degree from Clarkson University and an undergraduate degree from Nanjing University.
Hui Ping Jiang active positions
| Companies | Position | Start |
|---|---|---|
| VALERIO THERAPEUTICS | General Counsel | - |
Former positions of Hui Ping Jiang
| Companies | Position | End |
|---|---|---|
Qx Therapeutics, Inc. | President | - |
| EPIZYME, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Hui Ping Jiang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Clarkson University
 Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Qx Therapeutics, Inc. |
- Stock Market
- Insiders
- Hui Ping Jiang
